Energy for the Brain (MigraKet)
Safety, Tolerability and Efficacy of Exogenous Ketone Bodies for Preventive Treatment of Migraine: A Randomised, Placebo-controlled, Double-blind Study
Sponsor: University Hospital, Basel, Switzerland
Listed as NCT03132233, this NA trial focuses on Episodic Migraine and Migraine and remains completed. Sponsored by University Hospital, Basel, Switzerland, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2019 — Apr 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Nov 2018 — Dec 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jul 2017 — Oct 2017 [monthly]
Recruiting NA
-
May 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .